Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Hysteroscopic Myomectomy
NCT04996498Completed
- Sponsor
- Ain Shams University Maternity Hospital
- Start
- Apr 2021
- Primary completion
- Jul 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in leiomyoma comparing Oxytocin Group with Placebo Group (2 arms). Primary endpoints: Change in hemoglobin level and Change in hematocrit level. Started Apr 2021; status: completed.
02
Drugs
oxytocin
03
Conditions
leiomyoma
Beyond the preview
Go deeper on NCT04996498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04996498.